Continuous Flow Chemistry, Synthesis of Advanced Intermediates, Polymorph, Salt & Cocrystal Study, API Custom Synthesis, CDMO for High Potency APIs (HPAPIs), HPAPI Contract Manufacturing
Company intends to use the net proceeds from the offering for the previously announced registration study for VAL-083 in newly diagnosed and recurrent glioblastoma multiforme, the 15-patient REM-001 confirmatory lead-in study and for working capital.
This combination brings together DelMar's first-in-class, DNA-targeting chemotherapeutic with proven anti-cancer activities with Adgero's photodynamic therapy platform.